{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-232894","form_type":"8-K","ticker":"TXMD","cik":"0000025743","company_name":"TherapeuticsMD, Inc.","filed_at":"2022-08-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.720459+00:00","generated_at":"2026-06-23T20:33:46.222545+00:00","sec_items":["5.02","1.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"TherapeuticsMD appoints Rubric Capital partner Justin Roberts to board of directors","bullets":["Justin Roberts, Partner at Rubric Capital Management, appointed to fill newly created Board seat effective Aug. 23, 2022.","Board size increased to nine directors; Roberts will stand for election at 2022 Annual Meeting.","Rubric recently invested $15M in TherapeuticsMD via private placement of Series A Preferred and common stock (July 29, 2022).","Roberts has elected not to receive any director compensation at this time.","No other arrangements or material transactions between Roberts and Company beyond the Rubric investment."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-232894","json":"https://secwatch.observer/filing/0001193125-22-232894.json","markdown":"https://secwatch.observer/filing/0001193125-22-232894.md","text":"https://secwatch.observer/filing/0001193125-22-232894.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/25743/000119312522232894/0001193125-22-232894-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/25743/000119312522232894/d742359d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T20:33:46.222545+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a022f71184","claim":"Justin Roberts was appointed as Director at TherapeuticsMD, Inc..","evidence_excerpt":"On and effective as of August 23, 2022, the board of directors (the “Board”) of TherapeuticsMD, Inc., a Nevada corporation (the “Company”), appointed Mr. Justin Roberts as a director to fill a newly created vacancy on the Board as a result of the Board’s increase in the size of the Board by one director to a total of nine directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/25743/000119312522232894/0001193125-22-232894-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}